Pilot Study of Raltegravir Switch to Resolve Tenofovir Induced Proteinuria (RALPIR)
This study has been completed.
Sponsor:
Metropolis Medical
Collaborator:
Merck
Information provided by (Responsible Party):
Fritz Bredeek, MD, PhD, Metropolis Medical
ClinicalTrials.gov Identifier:
NCT01044771
First received: January 6, 2010
Last updated: October 25, 2012
Last verified: October 2012
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study has been completed. |
|---|---|
| Study Completion Date: | June 2011 |
| Primary Completion Date: | December 2010 (Final data collection date for primary outcome measure) |